CTN-0030 Protocol Book

← Back to document page

NIDA-CTN-0030A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic DependenceNATIONAL INSTITUTE ON DRUG ABUSECLINICAL TRIALS NETWORKProtocol ( 2007)CONTACT INFORMATION FOR INVESTIGATORS/COLLABORATORSTitleNameAffi liationLead Investigator for Protocol Implementation(LI)Roger Weiss, New England NodeLead Investigator for Protocol DevelopmentWalter Ling, NodeProject DirectorJennifer Sharpe Potter, , MPHNorthern New England NodeProject Co-DirectorAl Hasson, Pacific NodeProject ManagerKristi Prather, New England NodeMedical MonitorHilary Connery, , New England NodeSafety MonitorRobert Lindblad, Coordinating CenterBiostatisticiansEva Petkova, Island NodeJanet Levy, CCTNRegulatory SpecialistScott Provost, , New England NodeTraining DirectorMarc Copersino, New England NodeNIDA LiaisonsJack Blaine, CCTNPetra Jacobs, CCTNExecutive CommitteeFranklin Ingram, Carolina Node Carmen Masson, NodeMichael Bogenschutz, NodeJeff Selzer, Island NodeNathaniel Katz, New England NodeMichele Straus.

NIDA-CTN-0030 A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for …

  Protocol, 3000, Ctn 0030 protocol, Ctn 0030